Kimberly-clark Worldwide, Inc.

Hollister, Inc.

Richard Joseph Hantke

Heather Anne Sorebo

Mary Lou McDaniel

James John Hlaban

Susan Marie Weyenberg

Patricia A Mitchler

Thomas Patrick Keenan

Stephen Lanard Nunn

William Grover Reeves

Erica M Phillips

Talbot Presley

Daniel Duncan Baird

Mike Rainone

Thomas Edward Plowman

Garry Roland Woltman

Adrienne Rae Loyd

Sylvia Bandy Little

Teresa Marie Zander

Jennifer Elizabeth Pozniak

Ronald Lee Edens

Theodore T Tower

Kristi Jo Bryant

Laura J Keely

Angela Rae Heck

Sheila Marie Heyrman

Debra Ann Haase

Kim Hoertsch

MaryAnn Zunker

Shawn Ray Feaster

Cindy Lou Price

Jason Matthew English

Robin Ray Thompson

Alethea Angelic Marie Swiecicki

Corey James Pelz

John E Rdzok

Debra A Haase

Kim M Hoertsch

A catheter system () with a valve assembly () that expels excess inflation fluid when a cuff or balloon () of the catheter system is overinflated. The valve assembly includes a luer-activated spool () biased toward a sealed condition, a precision relief/check valve () biased toward a scaled condition, a primary valve body outlet (), a valve body feedback inlet (), and a secondary valve body outlet (). An inflation lumen () is in fluid communication with the primary valve body outlet and an interior of the cuff or balloon. A feedback lumen () is in fluid communication with the interior of the cuff or balloon and the valve body feedback inlet. When feedback fluid builds up pressure in excess of the restoring force of the relief spring, the relief/check valve opens, unsealing an expulsion pathway and relieving excess fluid from the cuff or balloon.

Inflation cuff with transient-resistant over-pressure preventor

A visually-coordinated absorbent product includes an absorbent article component including a garment side outer cover and a body side liner, wherein the article component has at least a first and second visual characteristic, and wherein the first visual characteristic is different from the second visual characteristic. The absorbent product also includes a first packaging component including at least first and second visual characteristics, wherein first and second visual characteristics of the absorbent article are coordinated to the first and second visual characteristics of the packaging component, and wherein at least a portion of one of the garment side outer cover and the body side liner is configured with the article component first visual characteristic and at least a portion of one of the garment side outer cover and the body side liner is configured with the article component second visual characteristic.

Visually-coordinated absorbent product

Disclosed herein are methods and devices for detection of bacterial HAI. Disclosed methods may be utilized for continuous in vivo monitoring of a potential bacterial infection site and may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of infection. Disclosed methods include utilization of recombinant bacteriophage to deliver to pathogenic bacteria a translatable genetic sequence encoding an optically detectable marker or an enzyme capable of producing an optically detectable marker. Upon detection of the optical signal produced by the marker, medical personnel may be alerted to the presence of pathogenic bacteria at the site of inquiry. Any bacterial causative agent of HAI may be detected according to disclosed methods.

Recombinant bacteriophage for detection of nosocomial infection

Disclosed are methods and devices for continuous in vivo monitoring of a potential bacterial infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of a hospital acquired infection, thereby providing for earlier intervention. Disclosed methods utilize optical fibers to deliver an excitation signal to an area in which pathogenic bacteria may exist. In the presence of the excitation signal, bacterial pathogens may autofluoresce with a unique spectral signature. Upon generation of a fluorescent emission, an optically detectable emission signal may be transmitted to a detection/analysis device. Analysis of the characteristics of the emission signal produced in response to the excitation signal may be used to determine the presence or concentration of pathogens at the site of inquiry, following which real time information may be transmitted to medical personnel via a wireless transmission system.

Fiber optic based detection of autofluorescent bacterial pathogens

A visually coordinated absorbent product includes a article component having a body side liner, a garment side outer cover and an absorbent core disposed between the body side liner and the garment side outer cover. The article component has at least a first and second visual characteristic, wherein the first visual characteristic is different than the second visual characteristic. The article component is disposed in a packaging component having at least the first and second visual characteristics. In one embodiment, the packaging component is an individual pouch sized and configured to hold a single, individual article component. In various embodiments, the visual characteristics can include color, embossment, printing, and/or side sealing.

Visually coordinated absorbent product

Disclosed herein are methods and devices for detection of hospital acquired infections. Disclosed methods may be utilized for continuous in vivo monitoring of a potential infection site or for periodic in vitro monitoring of tissue or fluid from a patient and may be utilized to alert patients and/or health care providers to the presence of a pathogen at an early stage of infection. Disclosed methods utilize fluorophore pairs that optically interact with one another according to Forster resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) mechanism. One member of the pair or a cofactor that interacts with an enzyme to form a member of the pair may be tethered to a device by a substrate that is specific for an enzyme expressed by a targeted pathogen. Upon interaction of the enzyme with the substrate, an optically detectable signal may be altered or initiated, detection of which may then provide information as to the existence of the pathogen at the site.

Resonance energy transfer based detection of nosocomial infection

A disposable intralabial urinary incontinence article having a resilient and liquid impermeable exostructure captures bodily exudates. The exostructure has a top surface and an internal space adapted to receive fluids. At least a portion of the exostructure is a flange that rests at least partially outside the labia. The exostructure also has a neck extending from the top surface that at least partially occupies the vestibular region and rests proximate the vestibule floor. The neck has a fluid receiving opening which is in communication with the internal space. The neck is configured so the fluid receiving opening is positioned generally adjacent the urethral meatus to direct urine into the internal space. The internal space may include an absorbent and the article may include a clitoral guide to aid positioning of the article within the vestibule.

Bodily exudate capturing article

An absorbent article having an absorbent structure sized and configured for insertion at least partially within the vestibule of a female wearer. The absorbent structure has a saturation capacity as determined by a Saturation Capacity and Retention Capacity Test of at least about 15 grams/gram, a retention capacity as determined by the Saturation Capacity and Retention Capacity Test of at least about 3 grams/gram, and an intake time for a first insult of the absorbent structure as determined by an Intake and Rewet Test of no more than about 30 seconds.

Labial pad

Tab for a labial pad

Portion of a labial pad

Growing community of inventors

Appleton, WI, United States of America

Richard Joseph Hantke